Real-world comparative effectiveness and safety of pembrolizumab for PD-L1≥50% metastatic non-small-cell lung cancer
Article in Future Oncology (May 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in Future Oncology (May 2024)
Article in Cancers (March 2024)
Article in Clinical Lung Cancer (December 2023)